Net income increased 79.3%
Net income changed +79.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +79.3% from the comparable as-filed period.
Trade receivables changed +20.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +24.5% from the comparable as-filed period.
Shares outstanding changed -5.3% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Operating margin changed +258 basis points from the comparable as-filed period.
Cash & equivalents changed -23.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Working capital / assets changed -610 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital changed -15.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Capex / revenue changed -654 basis points from the comparable as-filed period.
Cash & equivalents changed +25.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -45.7% from the comparable as-filed period.
Operating cash flow changed -51.9% from the comparable as-filed period.
Net income changed -26.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed -21.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed -464 basis points from the comparable as-filed period.
Shares outstanding changed -3.3% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Inventory / revenue changed +4288 basis points from the comparable as-filed period.
Capex / revenue changed -538 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.